Furthermore, MMR deficiency and risk of LS in CRC patients was more common in the deceased group than among those who survived, but this difference was only significant with respect to the MLH1 and PMS2 genes. This evidence concerns the gene MLH1 and mismatch repair cancer syndrome 1.